Which is not the opinion of some patients. “We consider not only that we have complied with the regulations, always with the approval of the authorities, but also that we have gone beyond what was imposed”, argues the lawyer. The debate will therefore focus on the communication plan that accompanied the arrival of the new Levothyrox formula. The investigating judge ruled out the most serious charges of prevention, namely homicide and involuntary injury as well as the endangerment of others, to retain only aggravated deception. “It is not the quality of the drug that is implicated, clarifies Mario Stasi, lawyer for the pharmaceutical firm. This molecule is taken daily by 2.3 million people in France to overcome the inability of their thyroid to produce levothyroxine, a hormone that plays a central role in the body. The French subsidiary of the German pharmaceutical company Merck announced on Wednesday morning its indictment for “aggravated deception” in the criminal investigation into the change in formula of the drug which, in 2017, had been followed by a wave of declaration of effects unprecedented undesirables. ![]() This is a new twist in the Levothyrox affair, which has hardly been talked about for several years. Justice will have to determine if there was a failure to inform patients during the change of formula in 2017. ![]() The manufacturer of this essential drug in hypothyroidism is indicted for “aggravated deception”.
0 Comments
Leave a Reply. |